Source: International Congress 2019 – Airway diseases and blood cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Azevedo Gigante (Vila Nova de Gaia, Portugal), E. Milheiro Tinoco (Vila Nova de Gaia, Portugal), T. Shiang (Vila Nova de Gaia, Portugal), R. Marçôa (Vila Nova de Gaia, Portugal), E. Silva (Vila Nova de Gaia, Portugal), C. Ribeiro (Vila Nova de Gaia, Portugal), M. Vanzeller (Vila Nova de Gaia, Portugal). COPD exacerbations: is eosinophilia a protective factor?. 2581

Member's Comments

No comment yet.

Related content which might interest you: Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Christmas as a risk factor for exacerbations of COPD, adult asthma and respiratory infections Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 A typical COPD exacerbation? Source: Breathe 2008; 4: 346-354 Year: 2008 Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Source: Eur Respir J 2007; 29: 906-913 Year: 2007 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma? Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017 Year: 2017 Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013